CD38 Antibodies in Multiple Myeloma: What Next?

Keeping Current
04/09/2020 33 min
CD38 Antibodies in Multiple Myeloma: What Next?

Listen "CD38 Antibodies in Multiple Myeloma: What Next?"

Descargar episodio Ver en sitio original

Episode Synopsis

Listen to Drs Mateos and Lonial discussing treatment options for managing patients with CD38-resistant MM. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/936677?src=mkm_podcast_addon_936677

More episodes of the podcast Keeping Current

The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology 05/01/2026
Achieving Brain Health in Epilepsy: What Can Clinicians Do? 05/01/2026
Patient Case Challenge: How Would You Manage This Patient With MASH? 31/12/2025
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies 24/12/2025
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences 19/12/2025
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy 18/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies 12/12/2025
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies 10/12/2025
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA